Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
0.5820
-0.0420 (-6.73%)
At close: Apr 4, 2025, 4:00 PM
0.5999
+0.0179 (3.08%)
After-hours: Apr 4, 2025, 7:50 PM EDT

Spero Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-68.5722.81-46.42-89.76-78.28
Upgrade
Depreciation & Amortization
00.370.870.650.76
Upgrade
Asset Writedown & Restructuring Costs
-5.310.64--
Upgrade
Loss (Gain) From Sale of Investments
--0.010.25-0.03
Upgrade
Stock-Based Compensation
7.797.939.129.434.89
Upgrade
Other Operating Activities
1.040.975.962.220.26
Upgrade
Change in Accounts Receivable
46.35-95.741.553.052.43
Upgrade
Change in Accounts Payable
5.930.76-0.48-0.05-2.98
Upgrade
Change in Unearned Revenue
-26.6329.0121.8910.64-
Upgrade
Change in Income Taxes
-0.210.39-0.78-0.25
Upgrade
Change in Other Net Operating Assets
10.84-4.79-0.87-1.56-12.67
Upgrade
Operating Cash Flow
-23.44-33-7.73-64.35-85.87
Upgrade
Capital Expenditures
-----0.16
Upgrade
Sale of Property, Plant & Equipment
---0.04-
Upgrade
Investment in Securities
--33.817.6310.63
Upgrade
Investing Cash Flow
--33.817.6710.47
Upgrade
Issuance of Common Stock
-0.2224.9336.8280.85
Upgrade
Other Financing Activities
---54.4947.23-0.95
Upgrade
Financing Cash Flow
-0.22-29.5584.05130.88
Upgrade
Net Cash Flow
-23.44-32.77-3.4827.3855.48
Upgrade
Free Cash Flow
-23.44-33-7.73-64.35-86.03
Upgrade
Free Cash Flow Margin
-48.86%-31.79%-14.45%-352.47%-922.07%
Upgrade
Free Cash Flow Per Share
-0.43-0.62-0.21-2.08-3.84
Upgrade
Cash Income Tax Paid
992.212.21---
Upgrade
Levered Free Cash Flow
-25.13-9.9-1.08-41.44-55.16
Upgrade
Unlevered Free Cash Flow
-25.13-9.90.55-40.22-55.16
Upgrade
Change in Net Working Capital
-12.3834.94-9.66-4.6811.21
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q